e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Asthma drugs: new findings
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Formoterol-induced downregulation of the beta2-adrenoceptor in asthmatics with homozygous glycine-16 polymorphism
L. Fuso, A. Di Perna, A. Longobardi, A. Trovè, M. Bisceglia, B. Bibi, C. Angelozzi, F. D. Tiziano, R. Antonelli Incalzi (Rome, Italy)
Source:
Annual Congress 2013 –Asthma drugs: new findings
Session:
Asthma drugs: new findings
Session type:
Thematic Poster Session
Number:
4119
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Fuso, A. Di Perna, A. Longobardi, A. Trovè, M. Bisceglia, B. Bibi, C. Angelozzi, F. D. Tiziano, R. Antonelli Incalzi (Rome, Italy). Formoterol-induced downregulation of the beta2-adrenoceptor in asthmatics with homozygous glycine-16 polymorphism. Eur Respir J 2013; 42: Suppl. 57, 4119
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Interaction between the Arg16 homozygous genotype, inhaled corticosteroids and long acting beta agonists for asthma exacerbations in children? Leukotriene receptor antagonists to the rescue?
Source: Annual Congress 2013 –Asthma and lung development: from genes to environment
Year: 2013
Effect of ADRB2 gene polymorphism on treatment outcomes in asthmatics: Cold airway hyperresponsiveness and asthma control
Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD
Year: 2014
VNTR polymorphism in IL1RN gene in COPD and bronchial astma in Bulgarian population
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013
Influence of beta2-adrenergic receptor polymorphism on methacholine hyperresponsiveness in asthmatic patients
Source: Annual Congress 2013 –Genetics and genomics of lung disease
Year: 2013
Assessment of asthma control in asthmatic patients Brazilian carriers of the Arg16Gly polymorphism of the β2 adrenorreceptor gene
Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma
Year: 2009
ADRB2 Gly16Arg polymorphism, asthma control and lung function decline
Source: Eur Respir J 2011; 38: 1029-1035
Year: 2011
Association between genetic polymorphisms of ADAM33 with asthma and its phenotypes
Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD
Year: 2015
Single nucleotide polymorphism of
PSMA6
gene in Lithuanian patients with asthma
Source: Annual Congress 2013 –Genetics and genomics of lung disease
Year: 2013
Effect of TRPV4 gene polymorphisms on osmotic airway hyperresponsiveness in patients with asthma
Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD
Year: 2015
ALOX15 gene polymorphisms in Japanese patients with aspirin-exacerbated respiratory disease (AERD)
Source: International Congress 2016 – Role of genetics and exposures in COPD and asthma
Year: 2016
GLCCI1
variant accelerates pulmonary function decline in patients with asthma receiving inhaled corticosteroids
Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD
Year: 2014
Relation of IL-33 and PSMA6 gene polymorphisms in asthma patients
Source: International Congress 2016 – Clinical studies in asthma and immunology
Year: 2016
TRPM8
gene polymorphisms and their relation to cold airway hyperresponsiveness in patients with bronchial asthma
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013
ADRB2, ADAM33 and AAT gene polymorphisms and IgE-mediated asthma in Russian patients
Source: Annual Congress 2011 - Biomarkers of allergic inflammation
Year: 2011
Association of C3435T polymorphism of MDR1 gene and T1808A polymorphism of NR3C1 gene with bronchial obstruction in severe asthmatics and COPD patients
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010
Impact of -1562 C/T polymorphism of
MMP9
gene on COPD susceptibility in Polish patients.
Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD
Year: 2014
?2-adrenergic receptor polymorphisms, asthma and COPD: two large population-based studies
Source: Eur Respir J 2012; 39: 558-566
Year: 2012
Re-sequencing of
IL33
and
IL1RL1
in severe asthma patients identifies novel variation
Source: International Congress 2014 – Genes and environment in asthma and COPD
Year: 2014
The linkage of Arg16Gly polymorphism of β
2
adrenoreceptor with expression of reversibility of bronchial obstruction of patients with atopic bronchial asthma in Kyrgyz nation
Source: Eur Respir J 2006; 28: Suppl. 50, 236s
Year: 2006
Polymorphic variants of genes ADRB2, NR3C1, MDR1 in patients with chronic obstructive pulmonary disease and obesity
Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept